Latest News and Press Releases
Want to stay updated on the latest news?
-
Austin, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Viral Vectors and Plasmid DNA Manufacturing Market Size & Growth Analysis: According to SNS Insider, the Viral Vectors and Plasmid DNA...
-
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new...
-
VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce updated and complete assay...
-
Vertero strengthens Board of Directors with Independent Chair R. Scott Greer, life sciences veteran, experienced executive, investor, and advisor.
-
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need With Fast Track designation, QTORIN™ rapamycin for...
-
Caliber has selected StoneX as an additional institutional platform for trading and custody in support of Caliber’s Digital Asset Treasury (DAT) Strategy.
-
Industry Leaders Point to Challenging Political and Economic EnvironmentKey Legislation Expected to Impact Supply Chain and Drug CostsRecent M&A Momentum Offset by Challenging Fundraising...
-
RENO, Nev., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology,...
-
PETAH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) (“Gilat” or the “Company”), a worldwide leader in satellite networking technology,...
-
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib from an...